General Information of the Compound
| Compound ID |
CP0847124
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(5-(4-Bromophenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)thiazol-4(5H)-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H14BrN3OS
|
||||||||||||||||||
| Molecular Weight |
400.301
|
||||||||||||||||||
| Canonical SMILES |
O=C1CSC(N2N=C(c3ccccc3)CC2c2ccc(Br)cc2)=N1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H14BrN3OS/c19-14-8-6-13(7-9-14)16-10-15(12-4-2-1-3-5-12)21-22(16)18-20-17(23)11-24-18/h1-9,16H,10-11H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
VZUOXKTTZJFLLO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2